- Home
- VERO vs TRIB Comparison
VERO vs TRIB Comparison
Compare VERO & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERO
- TRIB
- Stock Information
- Founded
- VERO N/A
- TRIB 1992
- Country
- VERO Canada
- TRIB Ireland
- Employees
- VERO N/A
- TRIB N/A
- Industry
- VERO Medical/Dental Instruments
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- VERO Health Care
- TRIB Health Care
- Exchange
- VERO Nasdaq
- TRIB Nasdaq
- Market Cap
- VERO 4.5M
- TRIB 5.4M
- IPO Year
- VERO N/A
- TRIB N/A
- Fundamental
- Price
- VERO $2.36
- TRIB $1.18
- Analyst Decision
- VERO
- TRIB
- Analyst Count
- VERO 0
- TRIB 0
- Target Price
- VERO N/A
- TRIB N/A
- AVG Volume (30 Days)
- VERO 43.6K
- TRIB 2.4M
- Earning Date
- VERO 11-12-2025
- TRIB 11-14-2025
- Dividend Yield
- VERO N/A
- TRIB N/A
- EPS Growth
- VERO N/A
- TRIB N/A
- EPS
- VERO N/A
- TRIB N/A
- Revenue
- VERO $60,107,000.00
- TRIB $61,555,000.00
- Revenue This Year
- VERO N/A
- TRIB $13.51
- Revenue Next Year
- VERO $7.51
- TRIB $13.14
- P/E Ratio
- VERO N/A
- TRIB N/A
- Revenue Growth
- VERO N/A
- TRIB 8.31
- 52 Week Low
- VERO $2.10
- TRIB $0.48
- 52 Week High
- VERO $14.50
- TRIB $3.44
- Technical
- Relative Strength Index (RSI)
- VERO 51.20
- TRIB 48.16
- Support Level
- VERO $2.27
- TRIB $1.42
- Resistance Level
- VERO $2.38
- TRIB $1.28
- Average True Range (ATR)
- VERO 0.11
- TRIB 0.09
- MACD
- VERO 0.01
- TRIB -0.04
- Stochastic Oscillator
- VERO 72.16
- TRIB 20.41
About VERO Venus Concept Inc.
Venus Concept Inc is a medical technology company. It develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The company's products include NeoGraft, Venus Viva, Venus Legacy, Venus Versa, Venus Velocity, Venus Bliss, ARTAS systems, and others. The company provides medical devices and treatments for hair, body, and skin-related problems. It generates a majority of its revenue from the United States.
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.